The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue.

Abstract

The nonmedical use of 'designer' cathinone analogs, such as 4-methylmethcathinone (mephedrone) and 3,4-methylenedioxymethcathinone (methylone), is increasing worldwide, yet little information is available regarding the mechanism of action for these drugs. Here, we employed in vitro and in vivo methods to compare neurobiological effects of mephedrone and methylone with those produced by the structurally related compounds, 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine. In vitro release assays using rat brain synaptosomes revealed that mephedrone and methylone are nonselective substrates for plasma membrane monoamine transporters, similar to MDMA in potency and selectivity. In vivo microdialysis in rat nucleus accumbens showed that i.v. administration of 0.3 and 1.0 mg/kg of mephedrone or methylone produces dose-related increases in extracellular dopamine and serotonin (5-HT), with the magnitude of effect on 5-HT being greater. Both methcathinone analogs were weak motor stimulants when compared with methamphetamine. Repeated administrations of mephedrone or methylone (3.0 and 10.0 mg/kg, s.c., 3 doses) caused hyperthermia but no long-term change in cortical or striatal amines, whereas similar treatment with MDMA (2.5 and 7.5 mg/kg, s.c., 3 doses) evoked robust hyperthermia and persistent depletion of cortical and striatal 5-HT. Our data demonstrate that designer methcathinone analogs are substrates for monoamine transporters, with a profile of transmitter-releasing activity comparable to MDMA. Dopaminergic effects of mephedrone and methylone may contribute to their addictive potential, but this hypothesis awaits confirmation. Given the widespread use of mephedrone and methylone, determining the consequences of repeated drug exposure warrants further study.

• Authors: Michael H Baumann, Mario A Ayestas Jr, John S Partilla, Jacqueline R Sink, Alexander T Shulgin, Paul F Daley, Simon D Brandt, Richard B Rothman, Arnold E Ruoho, Nicholas V Cozzi
• Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (Neuropsychopharmacology) Vol. 37 Issue 5 Pg. 1192-203 (Apr 2012) ISSN: 1740-634X [Electronic] England
• PMID: 22169943 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)

Chemical References

• Dopamine Plasma Membrane Transport Proteins
• Hallucinogens
• Membrane Transport Proteins
• Norepinephrine Plasma Membrane Transport Proteins
• Tritium
• Serotonin
• Methamphetamine
• mephedrone
• N-Methyl-3,4-methylenedioxyamphetamine
• methylone
• 1-Methyl-4-phenylpyridinium
• Dopamine

Topics

• 1-Methyl-4-phenylpyridinium (pharmacokinetics)
• Analysis of Variance
• Animals
• Chromatography, High Pressure Liquid
• Dopamine (metabolism)
• Dopamine Plasma Membrane Transport Proteins (metabolism)
• Dose-Response Relationship, Drug
• Electrochemistry
• Hallucinogens (pharmacology)
• In Vitro Techniques
• Locomotion (drug effects)
• Male
• Membrane Transport Proteins
• Methamphetamine (analogs & derivatives, chemistry, pharmacology)
• Microdialysis (methods)
• N-Methyl-3,4-methylenedioxyamphetamine (pharmacology)
• Norepinephrine Plasma Membrane Transport Proteins (metabolism)
• Nucleus Accumbens (drug effects, metabolism)
• Rats
• Rats, Sprague-Dawley
• Serotonin (metabolism, pharmacokinetics)
• Synaptosomes (drug effects)
• Time Factors
• Tritium (pharmacokinetics)